Mortality and morbidity of heart failure treated with digoxin. A propensity-matched study

International Journal of Clinical Practice

Volumn 65, Issue 12, 2011, Pages 1250-1258

  Andrey, J L ^a   Romero, S ^a   Garcia Egido A ^a   Escobar, M A ^a   Corzo, R ^a   Garcia Dominguez, G ^a   Lechuga, V ^a   Gomez F ^a  

^a HOSPITAL UNIVERSITARIO DE PUERTO REAL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

AGED; ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENDER; HEART FAILURE; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; SCORING SYSTEM;

AGED; CARDIOTONIC AGENTS; DIGOXIN; FEMALE; HEART FAILURE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; PROPENSITY SCORE; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 81755164735     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2011.02771.x     Document Type: Article

References (27)

1. The Digitalis Investigation Group. The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med 1997; 336: 525-33.
2. Uretsky BF, Young JB, Shahidi FE, Yelen LG, Harrison MC, Jolly MK,. Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: results of the PROVED trial. J Am Coll Cardiol 1993; 22: 955-62. (Pubitemid 23285742)
3. Packer M, Gheorghiade M, Young JB, et al., Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting enzyme inhibitors. N Engl J Med 1993; 329: 1-7. (Pubitemid 23182871)
4. Van Veldhuisen DJ, Man in't Veld AJ, Dunselman PH, et al., Double-blind placebo-controlled study of ibopamine and digoxin in patients with mild to moderate heart failure: results of the Dutch Ibopamine Multicenter Trial (DIMT). J Am Coll Cardiol 1993; 22: 1564-73. (Pubitemid 23336707)
5. Rathore SS, Wang Y, Krumholz HM,. Sex-based differences in the effect of digoxin for the treatment of heart failure. N Engl J Med 2002; 347: 1403-11. (Pubitemid 35239712)
6. Dickstein K, Cohen-Solal A, Filippatos G, et al., ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008. Eur J Heart Fail 2008; 10: 93-989.
7. McKee PA, Castelli WP, McNamara PM, Kannel WB,. The natural history of congestive heart failure: the Framingham study. N Engl J Med 1971; 285: 1441-6.
8. Gomez-Soto FM, Romero SP, Bernal JA, et al., Consultation between specialists in Internal Medicine and Family Medicine improves management and prognosis of heart failure. Eur J Intern Med 2008; 19: 548-54.
9. Rule AD, Larson TS, Bergstralh EJ, Slezak JM, Jacobsen SJ, Cosio FG,. Using serum creatinine glomerular filtration rate: accuracy in good health and in chronic kidney disease. Ann Intern Med 2004; 141: 929-37.
10. Charlson ME, Pompei P, Ales KL, MacKenzie CR,. A new method of classifying prognostic morbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373-83. (Pubitemid 17055592)
11. Redfield MM, Jacobsen SJ, Burnett JC, Mahoney DW, Bailey KB, Rodeheffer RJ,. Burden of systolic and diastolic ventricular dysfunction in the community. Appreciating the scope of the heart failure epidemic. JAMA 2003; 289: 194-202. (Pubitemid 36068707)
12. LeJemtel TH, Sonnenblick EH, Frishman WH,. Diagnosis and management of heart failure. In:, Fuster V, Alexander RW, O'Rourke RA, eds. Hurst's The Heart. 10th edn. New York, NY: McGraw-Hill, 2001: 778-807.
13. Ray JG, Gong Y, Sykora K, Tu JV,. Statin use and survival outcomes in elderly patients with heart failure. Arch Intern Med 2005; 165: 62-7. (Pubitemid 40096083)
14. Go AS, Lee WY, Yang J, Lo JC, Gurwitz JH,. Statin therapy and risks for death and hospitalization in chronic heart failure. JAMA 2006; 296: 2105-11. (Pubitemid 44664705)
15. Rubin DB,. On principles for modelling propensity scores in medical research. Pharmacoepidemiol Drug Saf 2004; 13: 855-7. (Pubitemid 40003820)
16. A'Agostino RB Jr,. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 1998; 17: 2265-81.
17. Rosenbaum PR,. Sensitivity analysis for matching with multiple controls. Biometrika 1988; 75: 577-81.
18. Lee D, Austin P, Rouleau J, Liu P, Naimark D, Tu J,. Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model. JAMA 2003; 290: 2581-7. (Pubitemid 37443288)
19. Therneau TM, Grambsch PM,. Modeling Survival Data: Extending the Cox Model. New York, NY: Springer, 2000.
20. Ahmed A, Rich MW, Fleg JL, et al., Effects of digoxin on morbidity and mortality in diastolic heart failure. The Ancillary Digitalis Investigation Group Trial. Circulation 2006; 114: 397-403. (Pubitemid 44264821)
21. Ahmed A, Waagstein F, Pitt B, et al., Effectiveness of digoxin in reducing one-year mortality in chronic heart failure in the Digitalis Investigation Group trial. Am J Cardiol 2009; 103: 82-7.
22. Adams KF, Patterson JH, Gattis WA, et al., Relationship of serum digoxin concentration to mortality and morbidity in women in the digitalis investigation group trial: a retrospective analysis. J Am Coll Cardiol 2005; 46: 497-504. (Pubitemid 41040292)
23. Ahmed A, Rich MW, Love TE, et al., Digoxin and reduction in mortality and hospitalization in heart failure: a comprehensive post hoc analysis of the DIG trial. Eur Heart J 2006; 27: 178-86. (Pubitemid 43069034)
24. Gheorghiade M, van Veldhuisen DJ, Colucci WS,. Contemporary use of digoxin in the management of cardiovascular disorders. Circulation 2006; 113: 2556-64. (Pubitemid 43948035)
25. Brouwer J, van Veldhuisen DJ, Man in't Veld AJ, et al., Heart rate variability in patients with mild to moderate heart failure: effects of neurohormonal modulation by digoxin and ibopamine. The Dutch Ibopamine Multicenter Trial (DIMT) Study Group. J Am Coll Cardiol 1995; 26: 983-90.
26. Rathore SS, Curtis JP, Wang Y, Bristow MR, Krumholz HM,. Association of serum digoxin concentration and outcomes in patients with heart failure. JAMA 2003; 289: 871-8. (Pubitemid 37430346)
27. Piña IL, O'Connor C,. BNP-guided therapy for heart failure. JAMA 2009; 301: 432-4.